Page last updated: 2024-11-02

phenobarbital and Alagille Syndrome

phenobarbital has been researched along with Alagille Syndrome in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Alagille Syndrome: A multisystem disorder that is characterized by aplasia of intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC), and malformations in the cardiovascular system, the eyes, the vertebral column, and the facies. Major clinical features include JAUNDICE, and congenital heart disease with peripheral PULMONARY STENOSIS. Alagille syndrome may result from heterogeneous gene mutations, including mutations in JAG1 on CHROMOSOME 20 (Type 1) and NOTCH2 on CHROMOSOME 1 (Type 2).

Research Excerpts

ExcerptRelevanceReference
"It has been stated that arteriohepatic dysplasia is a form of biliary paucity with a good prognosis."1.28Long-term complications of arteriohepatic dysplasia. ( Freese, D; Grothe, RM; Schwarzenberg, SJ; Sharp, HL; Snover, DC, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schwarzenberg, SJ1
Grothe, RM1
Sharp, HL1
Snover, DC1
Freese, D1

Other Studies

1 other study available for phenobarbital and Alagille Syndrome

ArticleYear
Long-term complications of arteriohepatic dysplasia.
    The American journal of medicine, 1992, Volume: 93, Issue:2

    Topics: Adolescent; Adult; Alagille Syndrome; Child; Child, Preschool; Cholestyramine Resin; Drug Therapy, C

1992